m-Opioid receptor (MOR) agonists represent the gold standard for the treatment of severe pain but may paradoxically also enhance pain sensitivity, that is, lead to opioid-induced hyperalgesia (OIH). We show that abrupt withdrawal from MOR agonists induces long-term potentiation (LTP) at the first synapse in pain pathways. Induction of opioid withdrawal LTP requires postsynaptic activation of heterotrimeric guanine nucleotide-binding proteins and N-methyl-D-aspartate receptors and a rise of postsynaptic calcium concentrations. In contrast, the acute depression by opioids is induced presynaptically at these synapses. Withdrawal LTP can be prevented by tapered withdrawal and shares pharmacology and signal transduction pathways with OIH. These findings provide a previously unrecognized target to selectively combat pro-nociceptive effects of opioids without compromising opioid analgesia. 14 neurons (Fig. 1, A and B ). This opioid withdrawal LTP remained undiminished for the remaining recording periods of up to 100 min. High doses of spinal morphine may lead to nonspecific OIH that is not mediated by opioid
O pioids are widely used by pain patients and by addicts. Abrupt withdrawal from acute opioid application may lead to opioid-induced hyperalgesia (OIH) that is also a key feature of the highly aversive withdrawal syndrome after prolonged opioid consumption (1) . Several mechanisms have been proposed to underlie OIH (2) (3) (4) (5) (6) (7) . It has been suggested that opioid-induced and injury-induced hyperalgesia share underlying mechanisms (8, 9) . A synaptic model of injury-induced hyperalgesia is the longterm potentiation (LTP) at synapses between nociceptive C fibers and neurons in superficial spinal dorsal horn (10, 11) . It is an intriguing but as yet unproven hypothesis that opioids may not only modify (12, 13) but also induce synaptic plasticity (13) . We tested this hypothesis directly. We used a slice preparation from rat lumbar spinal dorsal horn with long dorsal roots attached. Wholecell recordings were made from lamina I neurons with monosynaptic excitatory input from C fibers (14) . Bath application of the MOR agonist D-(-)-2amino-5-phosphonopentanoic acid (DAMGO) for 15 min induced a rapid, dose-dependent depression of C fiber-evoked excitatory postsynaptic currents (EPSCs) in all neurons tested without evidence of acute tolerance [inhibition was to 40 T 7% (SEM) at 2 min of application and to 39 T 7% at 15 min; Fig. 1, A and B ]. Upon washout of DAMGO, responses became potentiated to 165 T 17% of control 15 min after washout in 10 out of www.sciencemag.org SCIENCE VOL 325 10 JULY 2009 207 REPORTS receptors (15, 16) . We excluded any nonspecific effects by showing that acute depression and withdrawal LTP were both abolished by blockade of opioid receptors with naloxone (fig. S1) and by the MOR selective antagonist b-funaltrexamine ( Fig. 1C ). Any contribution of g-aminobutyric acid type A (GABA A ) or glycine receptors, for example by disinhibition of synaptic strength (17, 18) or block of LTP at inhibitory synapses (12) , can be ruled out because experiments were done in the presence of bicuculline and strychnine.
Blockade of postsynaptic heterotrimeric guanine nucleotide-binding proteins (G proteins) with guanosine 5´-O-(2´-thiodiphosphate) (GDP-b-S) included in the pipette solution abolished opioid withdrawal LTP without affecting the acute depression of synaptic strength in C fibers ( Fig. 1D ). This suggests that withdrawal LTP requires postsynaptic G protein signaling. In contrast, the depressant effect of opioids is induced presynaptically at these synapses.
OIH and activity-dependent forms of LTP at C fiber synapses require activation of N-methyl-D-aspartate (NMDA) receptors (8, 10) . Blockade of postsynaptic NMDA receptors by MK-801 added to the pipette solution fully blocked opioid withdrawal LTP without affecting acute synaptic depression by DAMGO ( Fig. 1E ). Adding the Ca 2+ chelator BAPTA [1,2-bis(2-aminophenoxy) ethane-N,N,N´,N´-tetraacetic acid] to the pipette solution had the same effect ( Fig. 1F ). OIH may develop during continuous chronic application of opioids or upon their withdrawal. The time point when opioids elevate intracellular calcium ion concentrations ([Ca 2+ ] i ) to cause LTP is, however, not known. We found that in individual lamina I neurons [Ca 2+ ] i may rise during acute opioid application ( Fig. 2A ), upon washout ( Fig. 2B ), or both ( Fig. 2C ). We next asked which of these different types of Ca 2+ rise is essential for the induction of withdrawal LTP. We used a caged form of BAPTA to chelate Ca 2+ ions in the postsynaptic neurons at defined time points by flash photolysis. When BAPTA was uncaged before DAMGO application, withdrawal LTP was prevented ( Fig. 1G ), confirming the previous experiment with BAPTA added to the pipette solution ( Fig. 1F ). Flash photolysis directly before the washout of DAMGO also fully blocked withdrawal LTP ( Fig. 1H ), indicating that a rise in postsynaptic [Ca 2+ ] i upon opioid withdrawal is essential for the induction of withdrawal LTP.
To evaluate whether opioid withdrawal LTP exists in the spinal cord of living animals with descending and segmental inhibitory systems intact, we next recorded C fiber-evoked field potentials in the superficial spinal dorsal horn of deeply anaesthetized adult rats (11) . We used the ultrashort-acting MOR agonist remifentanil, which induces OIH in humans and in rodents. Intravenous injections of remifentanil caused a rapid depression of C fiber-evoked field potentials to 30 T 8% within 5 min and to 33 T 8% at 60 min, suggesting that no acute tolerance developed. Upon abrupt termination of the infusion, responses were potentiated in 14 out of 16 animals tested (Fig. 3, A and B ). Mean potentiation was to 149 T 1% of control (n = 14) at 120 to 150 min after the infusion and remained undiminished throughout the recording period of up to 4 hours ( also abolished withdrawal LTP in vivo but had no effect on the acute depression by systemic remifentanil (Fig. 3E ). OIH apparently involves activation of protein kinase C (PKC) (19) (20) (21) . Consistently, spinal application of PKC blocker chelerythrine abolished induction of withdrawal LTP without affecting the acute depression of synaptic strength (Fig. 3F ).
Activity-dependent forms of LTP at C fiber synapses involve Ca 2+ release from intracellular ryanodine receptor-sensitive Ca 2+ stores and activation of calcium-calmodulin-dependent pro-tein kinase II (CaMKII) (11, 22, 23) . Blockade of ryanodine receptors by spinal superfusions with dantrolene blocked withdrawal LTP (Fig. 3G ), whereas spinal application of CaMKII blocker KN-93 was ineffective ( Fig. 3H ). Thus, opioid withdrawal LTP requires a rise in postsynaptic Ca 2+ , likely fueled by Ca 2+ influx through NMDA receptor channels and by the release from intracellular stores. Interestingly, the CaMKII blocker had no effect, either on acute depression or on potentiation. Signaling pathways between opioid withdrawal LTP and activity-dependent forms of LTP thus overlap only partially.
It is not known whether opioids may also raise Ca 2+ levels in spinal neurons in vivo. To test this directly, we used in vivo two-photon laserscanning microscopy and assessed Ca 2+ gradients in superficial dorsal horn neurons before, during, and after intravenous application of remifentanil. Of the 31 lamina I neurons tested, 15 responded with an elevation of Ca 2+ concentration to the application of the opioid. In 6 neurons Ca 2+ levels rose during drug application (Fig. 4A ). In 9 other neurons, Ca 2+ concentration remained constant during infusions but rose upon withdrawal from the opioid (Fig. 4B ). One might thus speculate that these two patterns of Ca 2+ rise consistently found in vivo and in vitro and involving distinct neuronal populations in superficial spinal dorsal horn may contribute to different forms of OIH. One that develops during continuous opioid application might contribute to opioid tolerance (8, 20, 24, 25) , and another one that may be part of the opioid withdrawal syndrome (21) .
We have identified an activity-independent form of LTP that is induced by withdrawal from acute application of MOR agonists. This opioid withdrawal LTP shares signal transduction pathways with OIH. Opioid withdrawal-and activitydependent forms of LTP (11, 22) at C fiber synapses require activation of NMDA receptors, rise in postsynaptic Ca 2+ , and activation of PKC. NMDA receptors have a PKC phosphorylation site, and phosphorylation removes the voltage-sensitive Mg 2+ block (26) . This may lead to NMDA receptor activation and Ca 2+ influx at or near the resting membrane potential in the absence of any presynaptic activity, possibly by glial cell-derived glutamate (27) or elevated glutamate levels during opioid withdrawal (28) .
OIH typically includes enhanced responsiveness to C fiber-mediated noxious mechanical and thermal stimuli (1) . Collectively the published and present data suggest that opioid withdrawal LTP at synapses of nociceptive C fibers is a mechanism of OIH. We found that withdrawal LTP can be prevented by a tapered withdrawal regime and that it is mechanistically and spatially distinct from opioid-induced synaptic depression. This encourages hopes that OIH may be targeted specifically without interfering with powerful opioid analgesia. Fig. 4 . In vivo imaging of Ca 2+ gradients in superficial spinal dorsal horn neurons during application and upon washout of an opioid. A cardiopulmonary bypass was used to improve mechanical stability (14) . Ca 2+ gradients of a total of 31 neurons were monitored. (A) Six neurons responded with elevated Ca 2+ levels during opioid application (P < 0.001). (B) Nine other neurons displayed Ca 2+ rise upon washout (P < 0.001). Sixteen neurons did not respond with a significant change in [Ca 2+ ] i to opioid application. Each neuron is represented by a different color. 
Electrophysiological recordings in vitro
Neurons were visualized with infrared optics (S1). Only neurons lying within a distance of maximally 20 µm from the dorsal white/grey matter border were considered as being lamina I neurons and used for the experiments. All recordings were made in the whole-cell patchclamp configuration at a holding potential of −70 mV using an Axopatch 200B patch-clamp amplifier and the pCLAMP 9 acquisition software. Signals were low-pass filtered at 2-10 kHz, sampled at 10 kHz. Patch pipettes (impedance 2-5 MΩ) from borosilicate glass were pulled on a horizontal puller and filled with internal solution (mM): potassium gluconate 120, KCl 20, MgCl 2 2, Na 2 ATP 2, NaGTP 0.5, HEPES 20, EGTA 0.5, ph 7.28 with KOH, measured osmolarity 300 mosm·l -1 . For some experiments, patch pipettes were filled with a K + free solution composed of (in mM): CsMeSO 3 , 120; TEA-Cl, 20; MgCl 2 , 2; HEPES, 10; EGTA, 10; Na 2 ATP, 2; and GDPβS, 500 µM. The potassium free GDPβS-solution was used to prevent postsynaptic opioid receptor mediated effects (S2, S3). For blocking intracellular Ca 2+ the Ca 2+ -chelator BAPTA (20 mM) was added to the pipette solution consisting of (in mM): potassium gluconate 100, KCl 20, MgCl 2 4, Na 2 ATP 2, NaGTP 0.5, HEPES 10, ph 7.28 with KOH, measured osmolarity 300 mosm·l -1 . For blocking postsynaptic NMDA-receptors MK-801 (10 µM) was added to the standard internal solution. Dorsal root afferents were stimulated through a suction electrode with an isolated current stimulator. After determination of the threshold to elicit an EPSC, test pulses of 0.1 ms were given at intervals of 30 s. Intensity of test stimulation ranged from 3 to 5 mA. Evoked EPSCs were classified as C-fiber-evoked when the calculated conduction velocity was below 0.5 m·s -1 . Monosynaptic C-fiber input was identified by the absence of failures in response to 10 stimuli applied at 2 Hz to the dorsal roots and a jitter in response latencies of less than 2 ms.
In some experiments electrophysiology was combined with UV-flash photolysis. For flash photolysis Diazo-2 tetrapotassium salt (2 mM) was added to the pipette solution composed of (in mM): potassium gluconate 120, KCl 20, MgCl 2 2, Na 2 ATP 2, NaGTP 0.5, HEPES 20, ph 7.28 with KOH, measured osmolarity 300 mosm·l -1 . Uncaging was performed with a UV-flash (Mercury Lamp 100 W) at 360 nm for 1 sec.
In vitro Ca 2+ imaging of spinal cord neurons
Fluorometric measurements of free cytosolic Ca 2+ concentrations of single lamina I dorsal horn neurons were performed by loading the cells in the recording chamber via a patch pipette by replacing EGTA in the standard pipette solution with the cell-impermeant dye fura-2 pentapotassium salt (250 µM). Slices were continuously superfused with recording solution containing bicuculline and strychnine. Experiments were performed at 33°C. Neurons were clamped at −70 mV in the whole cell patch-clamp configuration. For Ca 2+ imaging, cells were illuminated with a monochromator and images were taken with a cooled CCD camera. Paired exposures to 340 and 380 nm were obtained at a frame rate of 0.2 Hz. In all experiments, one drug effect was tested per slice.
Animal surgery for in vivo experiments
Experiments were performed on adult male Sprague Dawley rats (200-250 g for electrophysiology and 90-120 g body weight for imaging). Isoflurane (4 vol %) in two thirds N 2 O and one third O 2 was initially applied through an anesthesia mask to induce anesthesia. Animals were then intubated using a 16 G venous cannula and mechanically ventilated at a rate of 75 strokes·min -1 and a tidal volume of 4-6 ml. Anesthesia was maintained using 1.5 vol % isoflurane. Core temperature was kept at 37.5 ± 2°C with a feedback controlled heating blanket. Deep surgical level of anesthesia was verified by stable mean arterial blood pressure. The right femoral vein and artery were cannulated to allow i.v. infusions and for monitoring arterial blood pressure, respectively. Muscle relaxation was achieved by 2 μg⋅kg -1 ⋅h -1 pancuronium bromide i.v.. For cardiopulmonary bypass (see below) inand outflow a carotid artery and a jugular vein were cannulated. During anesthesia, animals continuously received i.v. solution (58% Ringer solution, 30% HAES, 8% glucose and 4% sodium bicarbonate, 2 ml·h -1 ) for stabilization of blood pressure (mean arterial blood pressure 120 ± 10 mmHg), blood-glucose (mean 100 ± 10 mg·dl -1 ) and base excess (−1.5 ± 0.8 mmol·l -1 ). Following cannulation, the left sciatic nerve was dissected free for bipolar electrical stimulation with a silver hook electrode. The lumbar segments L4 and L5 were exposed by laminectomy. The dura mater was incised and reflected. A portable stereotactic frame with two adjustable brackets for vertebral column fixation was custom made to fit on the microscope stage for imaging experiments (see below). The stereotactic frame permitted a prone position of the animal for cardiopulmonary bypass and for electrophysiological recordings in vivo. An agarose pool was formed around the exposed spinal segments and filled with artificial cerebrospinal fluid. A bipolar hook stimulation electrode was fixed directly onto the steel base plate for stimulation of sciatic nerve fibers. At the end of each electrophysiological experiment animals were decapitated in deep anesthesia, the spinal cord was removed and cryo-fixed for detection of a rhodamine B spot at the recording site under a fluorescence microscope. Only those experiments were taken into further analysis where the recording site was in laminae I or II.
Electrophysiological recordings in vivo
Electrophysiological recordings were performed as described elsewhere (S4) . Briefly, C-fiberevoked field potentials were recorded with glass electrodes (impedance 2-3 MΩ) from laminae I and II of the spinal cord dorsal horn in response to stimulation of sciatic nerve fibers. The pipette solution consisted of (in mM) NaCl 135, KCl 5.4, CaCl 2 1.8, Hopes 10 and MgCl 2 1, and in addition 0.2 % rhodamine B. At the end of each electrophysiological experiment, pressure was applied to the electrode (300 mbar, 1 min) for marking the recording site with rhodamine B. Electrodes were driven by a microstepping motor. Recordings were made with an ISO-DAM-amplifier using a band width filter of 0.1 -1000 Hz. Signals were monitored on a digital oscilloscope and digitized by an A/D converter. Afferent input from the hindpaw was identified by mechanical stimulation of the foot while acoustically evaluating the evoked responses with an audio monitor. Test stimuli were delivered to the sciatic nerve and consisted of single pulses of 0.5 ms at intensity of 25 V given every 5 minutes using an electrical stimulator.
To explore the signal transduction pathways involved, specific blockers were topically applied to the spinal cord dorsum (S5).
Cardiopulmonary bypass for in vivo Ca

2+ imaging experiments
The extracorporal circuit consisted of a venous reservoir, a membrane oxygenator and a heat exchanger. Blood was drained from the right atrium via the jugular vein catheter into a 5 ml reservoir, which was closed for generation of a slight vacuum to support venous outflow. The venous reservoir was connected to a roller pump equipped with a 12 cm long silicone tube with a 2 mm internal diameter. A heat exchanger was located between the roller pump and the oxygenator. The membrane oxygenator made of micro porous polypropylene fibers was custom built. Cardiopulmonary bypass was conducted during imaging at a flow rate of 150 ml·kg -1 ·min -1 , which is similar to normal cardiac output in the rat (S6) . Thereby sufficient blood gas exchange was provided throughout the whole cardiopulmonary bypass period. Blood pressure and arterial blood gas analyses were thereby kept within physiological limits.
In vivo dye loading of spinal cord neurons
Freshly made 250 μM Oregon Green BAPTA-1 AM (solved in 0.5 % Pluronic 127 in buffer) was pressure injected into superficial laminae of the exposed spinal cord. The proper injection area was identified by field potential recordings which were evoked by electrical stimulation of sciatic nerve fibers (see below). Following 30 min de-esterification of the dye, the animal was placed under the 2-photon laser-scanning microscope for imaging. To eliminate movement artefacts from respiration, a cardiopulmonary bypass was used during imaging.
In vivo Ca 2+ imaging of spinal cord neurons
Imaging was performed on a 2-photon laser scanning microscope consisting of a DM LFS A microscope and a femtosecond Ti-sapphire laser operating at 90 MHz repeat frequency, 140 fs pulse width and a wavelength range of 705 -980 nm. Excitation light was focused by an x40 water immersion objective (0.8 NA). The excitation wavelength was set to 750 nm for Oregon Green BAPTA. The average power delivered to the spinal cord surface was less than 200 mW. Scanning and imaging acquisition were controlled with confocal software. Emitted light was collected by a non-descanned detector for monitoring the calcium dye Oregon Green BAPTA (525/50). Long-term fluorescent measurements were achieved by repeatedly bidirectional scanning of a region of 512 x 128 pixels at a time interval of 300 ms -6 s and heart beat triggered. Fast fluorescent scanning at a region of 128 x 64 or 256 x 128 pixels was done at a time interval 92 -184 ms.
Drugs
For in vitro electrophysiology and in vitro Ca 2+ imaging experiments, drugs were applied to the bath solution at know concentrations. Drugs used were bicuculline (10 µM), strychnine (10 µM), the selective µ-opioid receptor agonist [D-Ala2, N-Me-Phe4, Gly-ol]-enkephalin (DAMGO, 500 nM) and β-funaltrexamine (25 µM). For in vivo recording pancuronium bromide was given as an i.v. infusion (2 mg·kg -1 ·h -1 ). Remifentanil was dissolved in sterile NaCl. For a tapered withdrawal remifentanil infusion was reduced from 450 µg·kg -1 ·h -1 to zero in 15 equal steps at 2 min intervals beginning 60 min after onset of infusion (Fig. 3C ). β-Funaltrexamine was applied topically onto the spinal cord surface (250 µM). The competitive N-methyl Daspartate (NMDA) receptor antagonist D(-)-2-Amino-5-phosphonopentanoic acid (D-AP5, 100 µM) was dissolved in 0.9% NaCl. The protein kinase C (PKC) blocker chelerythrine chloride (800 µM) was dissolved in ddH 2 O. The Ca 2+calmodulin dependent kinase II (CaMKII) blocker 2-[N-(2-hydroxyethyl)]-N-(4methoxybenzenesulfonyl)]amino-N-(4chlorocinnamyl)-N-methylbenzylamine (KN-93, 400 µM) and the ryanodine receptor blocker dantrolene (500 µM) were dissolved in DMSO. All drugs were further dissolved in artificial cerebrospinal fluid to obtain the desired concentrations as indicated in the figure legend and applied directly onto the spinal cord dorsum (S5).
Data analysis and statistics
C-fiber-evoked EPSCs were analyzed offline using Clampfit 9. Synaptic strength was quantified by measuring the peak amplitude of monosynaptic EPSCs. Amplitudes were used to quantify synaptic strength as they were not affected by occasional action potential discharges. The mean amplitude of 6 EPSCs evoked by test stimuli prior to opioid application served as control. Statistical comparison was assessed using SigmaStat 3.1. Data were tested for normality (Kolmogorov-Smirnov Test), and then a one way repeated measures analysis of variance (One Way RM-ANOVA) was performed for each neuron to test for potentiation. Effects of drugs were tested using the Fisher Exact test. The area under the curve of C-fiber-evoked field potentials was determined offline using the software Clampfit 9. Amplitudes and areas under the curve of C-fiber-evoked field potentials changed in parallel in all experiments. For data analysis the area under the curve was used as amplitudes displayed higher variability (coefficients of variation of up to 200%; on average 25%). The mean area under the curve of 18 consecutive field potentials prior opioid application served as control. Responses were normalized for each rat. Data were tested for normality, and then a One Way RM-ANOVA was performed to compare the different experimental protocols and treatments. ANOVA was corrected by the Bonferroni adjustment. Effects of drugs were tested using the Fisher Exact test. A p-value < 0.05 was considered statistically significant. Values are expressed as mean ± standard error of mean (SEM). In vivo Ca 2+ transients were measured using 512 x 128 pixels scans at a time interval of 6 s. Images were processed and quantified with ImageJ 1.37c. Fluorescence was averaged over cell body areas and expressed as relative fluorescence changes (F/F 0 ) after subtraction of background fluorescence. The 10 min periods prior to drug application or washout of the opioid served as controls. Data were tested for normality and changes in fluorescence intensity were assessed using the Rank-Sum test. Values are plotted as running averages with a sampling proportion of 0.05. For in vitro Ca 2+ imaging, the ratio of exposures to 340 and 380 nm light (F340/F380) was calculated off-line to assess the relative change in Ca 2+ -concentration without conversion to absolute concentration values. For single cell measuring, a region of interest was placed in the centre of the cell soma. Data were normalized to the period 1 min prior drug application. To assess changes in fluorescence intensity due to drug application a One Way RM-ANOVA was performed. ANOVA was corrected by the Bonferroni adjustment. Data are expressed as mean ± standard error of mean (SEM).
Fig S1.
Opioid-induced acute depression and opioid withdrawal LTP are blocked by the opioid-receptor antagonist naloxone. The average time course of C-fiber evoked EPSCs in lamina I neurons is shown. Bath application of naloxone (10 µM) fully blocked both, acute depression and LTP induction in all 5 neurons tested (p = 0.011).
Fig S2.
Intravenous infusion of remifentanil induces LTP at C-fiber synapses in vivo. In all graphs, mean time course of area under the curve of C-fiber evoked field potentials are shown. Values were normalized to pre-drug values (dotted line) and plotted against time (min). (A) Bolus injection (30 µg·kg -1 , downward arrow) of remifentanil led to potentiation of C-fiber evoked field potentials upon wash-out of the opioid in 3 animals (closed circles, p = 0.001) whereas it had no effect in 2 other animals tested (open circles, p = 0.375). (B) Remifentanil injected as a bolus followed by an infusion (450 µg·kg -1 ·h -1 , black horizontal bar) for 30 min induced LTP in 4 animals tested (closed circles, p = 0.004). No effect was observed in one animal (open circles, p = 0.266). (C) Spinal superfusion with naloxone (10 µM, open horizontal bar) abolished acute depression and opioid withdrawal LTP in all 5 animals that received a one hour remifentanil infusion (p = 0.001). (D) The commercially available formula of remifentanil contains glycine as a vehicle. Intravenous injection of glycine in the appropriate concentration (S7, S8) for one hour (closed bar) had no effect in any of the 4 animals tested (p = 0.001).
